Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Novel treatment strategies for prostate cancer: Senescence, senolytics and myelo...
Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland
Novel treatment strategies for prostate cancer: Senescence, senolytics and myeloid derived suppressor cells ( Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland )
9 Apr 2020
Immune checkpoint based approaches in AML and MDS
Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA
Immune checkpoint based approaches in AML and MDS ( Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA )
8 Apr 2020
Treating TRK fusion cancer: Selecting between available agents
Prof Marc Peeters and Dr David Hong
Treating TRK fusion cancer: Selecting between available agents ( Prof Marc Peeters and Dr David Hong )
3 Apr 2020
CARTs for the treatment of T-cell malignancies
Dr John DiPersio - Siteman Cancer Center, St. Louis, USA
CARTs for the treatment of T-cell malignancies ( Dr John DiPersio - Siteman Cancer Center, St. Louis, USA )
1 Apr 2020
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast c...
Dr. Geraldo Alves - Hospital Santa Rosa, Brasil
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer ( Dr. Geraldo Alves - Hospital Santa Rosa, Brasil )
26 Mar 2020
Haematological malignancies: Latest advances from ASH 2019
Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay
Haematological malignancies: Latest advances from ASH 2019 ( Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay )
10 Mar 2020
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019
Prof Marc Peeters and Prof Jesus Garcia-Foncillas
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019 ( Prof Marc Peeters and Prof Jesus Garcia-Foncillas )
9 Mar 2020
Management of mutation-negative NSCLC
Dr Vijay Patil - Tata Medical Center, Kolkata, India
Management of mutation-negative NSCLC ( Dr Vijay Patil - Tata Medical Center, Kolkata, India )
6 Mar 2020
Management of advanced cervical cancer
Dr Avinash Pandey - State Cancer Institute, Patna, India
Management of advanced cervical cancer ( Dr Avinash Pandey - State Cancer Institute, Patna, India )
6 Mar 2020
Systematic therapy of driver mutated NSCLC
Dr Vijay Patil - Tata Medical Center, Kolkata, India
Systematic therapy of driver mutated NSCLC ( Dr Vijay Patil - Tata Medical Center, Kolkata, India )
6 Mar 2020
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC
Dr Julie Graff - Oregon Health & Science University, Portland, USA
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC ( Dr Julie Graff - Oregon Health & Science University, Portland, USA )
19 Feb 2020
Integrative molecular characterisation of S/R RCC to reveal determinants of poor...
Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Integrative molecular characterisation of S/R RCC to reveal determinants of poor prognosis and response to ICIs ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020